Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1F | O60840 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.39 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.39 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17822082 | 0.94 | CACNA1F (0.39) | CACNA1FCHRM2CHRM1ADRA2BCHRM3 | |
| SCHEMBL11966005 | 0.94 | — | — | |
| SCHEMBL271024 | 0.94 | — | — | |
| SCHEMBL11966006 | 0.94 | — | — | |
| SCHEMBL17822029 | 0.92 | CACNA1F (0.40) | CACNA1FCHRM2CHRM1ADRA2BCHRM3 | |
| SCHEMBL17046104 | 0.79 | CACNA1F (0.55) | CACNA1FCHRM2CHRM1ADRA2BCHRM3 | |
| SCHEMBL438988 | 0.74 | — | — | |
| SCHEMBL7775143 | 0.74 | — | — | |
| SCHEMBL6200856 | 0.74 | — | — | |
| SCHEMBL7812892 | 0.74 | CA12 (0.33) | ALDH1A1TP53HSP90AA1CYP3A4THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3535436-B1 | PRECURSORS AND FLOWABLE CVD METHODS FOR MAKING LOW-K FILMS TO FILL SURFACE FEATURES | VERSUM MAT US LLC (US) | 2021-05-12 | — | — | EP | claimed |
| EP-3535436-B1 | PRECURSORS AND FLOWABLE CVD METHODS FOR MAKING LOW-K FILMS TO FILL SURFACE FEATURES | VERSUM MAT US LLC (US) | 2021-05-12 | — | — | EP | disclosed |
| US-10294250-B2 | Organoaminosilanes and methods for making same | VERSUM MATERIALS US, LLC (US) | 2019-05-21 | — | — | US | disclosed |
| EP-3395822-A1 | ORGANOAMINOSILANES AND METHODS FOR MAKING SAME | Versum Materials US, LLC (US) | 2018-10-31 | — | — | EP | disclosed |
| US-20170204120-A1 | Organoaminosilanes and Methods for Making Same | VERSUM MATERIALS US, LLC (US) | 2017-07-20 | — | — | US | disclosed |
| US-20150246937-A1 | ORGANOAMINOSILANES AND METHODS FOR MAKING SAME | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150246937-A1 | ORGANOAMINOSILANES AND METHODS FOR MAKING SAME | DDAH1, IDUA, DDT | CACNA1F 4060/4885CHRM2 4180/4885CHRM1 3778/4885 |
| US-20170204120-A1 | Organoaminosilanes and Methods for Making Same | DDAH1, IDUA, DDT | CACNA1F 4060/4885CHRM2 4180/4885CHRM1 3778/4885 |
| US-10294250-B2 | Organoaminosilanes and methods for making same | DDAH1, IDUA, DDT | CACNA1F 4060/4885CHRM2 4180/4885CHRM1 3778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.